🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Phase I study aiming at: * establishing the pharmacokinetic profile of int...
Status
Completed
Location
Multiple Locations
Start Date
2006-05
Trial ID
NCT02517788
This randomized phase III trial studies octreotide acetate and recombinant ...
Status
Active Not Recruiting
Location
Providence Hospital
Start Date
2007-12-01
Trial ID
NCT00569127
Treatments Being Tested
This phase I/IIa trial tests the safety, side effects, and best dose of che...
Status
Terminated
Location
Roswell Park Cancer Institute
Start Date
2024-02-16
Trial ID
NCT05756166
This trial proposes to evaluate the immunologic and potential clinical effe...
Status
Not Yet Recruiting
Location
UMPC Hillman Cancer Center
Start Date
2026-08
Trial ID
NCT07634094
Treatments Being Tested
Phase I study aiming at: * assessing the absolute bioavailability, pharmac...
Status
Completed
Location
Multiple Locations
Start Date
2005-05
Trial ID
NCT02515695
Treatments Being Tested
This randomized phase II trial studies how well ipilimumab with or without ...
Status
Completed
Location
University of Alabama at Birmingham Cancer Center
Start Date
2013-03-25
Trial ID
NCT01708941
Treatments Being Tested
This randomized phase III trial studies ipilimumab to see how well it works...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2011-06-17
Trial ID
NCT01274338
Treatments Being Tested
This randomized phase III trial studies how well pembrolizumab works compar...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2015-11-10
Trial ID
NCT02506153